| Marek s disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. | None |
| Marek_s disease virus microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-beta signaling pathway. | None |
| Data indicate that proto-oncogene c-MYC is necessary and sufficient to confer resistance to everolimus. | None |
| Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC. | None |
| Quadruplex forming promoter region of c-myc oncogene as a potential target for a telomerase inhibitory plant alkaloid, chelerythrine. | None |
| Restriction fragment length polymorphism as a genetic marker of the c-myc oncogene in rats. | None |
| Data show that broad association of myc proto-oncogene protein MYC with chromatin depends on interaction with the WD40-repeat protein WDR5. | None |
| BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene. | None |
| MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection. | None |
| A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors. | None |
| [CCCTC-binding protein: a new nuclear protein factor which interaction with 5 -flanking sequence of chicken c-myc oncogene correlates with repression of the gene]. | None |
| data suggest that oncogenic MYC confers a collateral stress on splicing, and so components of the spliceosome may be therapeutic entry points for aggressive MYC-driven cancers | None |
| Exploration of the selective recognition of the G-quadruplex in the N-myc oncogene by electrospray ionization mass spectrometry. | None |
| Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters. | None |
| Expression of c-myc proto-oncogene in normal human intestinal epithelium. | None |
| The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways. | None |
| detected coordination between regulation of transcription and translation upon modulation of Myc activity and showed connection of these responses to mTOR signaling to enhance oncogenic transformation and to the TGFbeta pathway to modulate cell migration and invasiveness | None |
| Data show that Omomyc protein co-localized with proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5) and histone H4 H4R3me2s-enriched chromatin domains. | None |
| Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. | None |
| Limitations in the measurement of c-myc oncoprotein and other nuclear antigens by flow cytometry. | None |